The Ministry of Health and Prevention (MoHAP) says stronger partnerships will help support the Ministry’s plans and programs to enhance drug sustainability in the UAE.
This was stated during a meeting with the Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG), headed by H.E. Dr. Amin Hussein Al Amiri, the Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, in the presence of Mazen Tarouty, General Manager, MSD Gulf.
Participants highlighted the UAE’s innovative infrastructure that is attractive to international pharmaceutical companies and the legislative environment that preserves stakeholder rights, which is of great importance to the medical and pharmaceutical industries.
The meeting called for a framework to allow international pharmaceutical companies to set up business in the UAE and form alliances with local companies to increase the number of locally-manufactured pharmaceutical products, enhance their quality and efficiency, and reduce production costs.
Dr. Amin Hussein Al Amiri said MoHAP welcomes closer ties with international partners.
“We also encourage them to work jointly with our local pharmaceutical factories to transform innovative biomedicine technologies into the labs of local pharma companies,” said Al Amiri.
UAE launches aid mission for hurricane-hit Caribbean nations
New paid parking zones introduced in Dubai
H.H. Sheikh Khaled holds talks with South Korean President
UAE fuel prices to drop in November
